NCT06191458View on ClinicalTrials.gov

Postpartum Primaquine in Breast Milk

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

February 23, 2025

Study Completion Date

February 23, 2025

Conditions
Postpartum Women
Interventions
DRUG

Primaquine

Primaquine 0.5 mg/kg (Government Pharmaceutical Organization, Thailand) will be given once daily with food for 14 days. This is the dose recommended by the World Health Organization for radical cure of P. vivax in tropical regions. Doses will be directly supervised (DOT).

Trial Locations (1)

63140

Shoklo Malaria Research Unit (SMRU), Mae Ramat

All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

University of Oxford

OTHER

NCT06191458 - Postpartum Primaquine in Breast Milk | Biotech Hunter | Biotech Hunter